Literature DB >> 23168163

CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFα.

Guangwen Ren1, Xin Zhao, Ying Wang, Xin Zhang, Xiaodong Chen, Chunliang Xu, Zeng-rong Yuan, Arthur I Roberts, Liying Zhang, Betty Zheng, Ting Wen, Yanyan Han, Arnold B Rabson, Jay A Tischfield, Changshun Shao, Yufang Shi.   

Abstract

Mesenchymal stromal cells (MSCs) tend to infiltrate into tumors and form a major component of the tumor microenvironment. These tumor-resident MSCs are known to affect tumor growth, but the mechanisms are largely unknown. We found that MSCs isolated from spontaneous lymphomas in mouse (L-MSCs) strikingly enhanced tumor growth in comparison to bone marrow MSCs (BM-MSCs). L-MSCs contributed to greater recruitment of CD11b(+)Ly6C(+) monocytes, F4/80(+) macrophages, and CD11b(+)Ly6G(+) neutrophils to the tumor. Depletion of monocytes/macrophages, but not neutrophils, completely abolished tumor promotion of L-MSCs. Furthermore, L-MSCs expressed high levels of CCR2 ligands, and monocyte/macrophage accumulation and L-MSC-mediated tumor promotion were largely abolished in CCR2(-/-) mice. Intriguingly, TNFα-pretreated BM-MSCs mimicked L-MSCs in their chemokine production profile and ability to promote tumorigenesis of lymphoma, melanoma, and breast carcinoma. Therefore, our findings demonstrate that, in an inflammatory environment, tumor-resident MSCs promote tumor growth by recruiting monocytes/macrophages.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23168163      PMCID: PMC3518598          DOI: 10.1016/j.stem.2012.08.013

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  58 in total

Review 1.  Marrow stromal cells as stem cells for nonhematopoietic tissues.

Authors:  D J Prockop
Journal:  Science       Date:  1997-04-04       Impact factor: 47.728

2.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.

Authors:  L A Donehower; M Harvey; B L Slagle; M J McArthur; C A Montgomery; J S Butel; A Bradley
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

3.  Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair.

Authors:  T A Prolla; S M Baker; A C Harris; J L Tsao; X Yao; C E Bronner; B Zheng; M Gordon; J Reneker; N Arnheim; D Shibata; A Bradley; R M Liskay
Journal:  Nat Genet       Date:  1998-03       Impact factor: 38.330

4.  Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis.

Authors:  Li Yang; Laura M DeBusk; Koari Fukuda; Barbara Fingleton; Brenda Green-Jarvis; Yu Shyr; Lynn M Matrisian; David P Carbone; P Charles Lin
Journal:  Cancer Cell       Date:  2004-10       Impact factor: 31.743

5.  Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals.

Authors:  Farida Djouad; Pascale Plence; Claire Bony; Philippe Tropel; Florence Apparailly; Jacques Sany; Danièle Noël; Christian Jorgensen
Journal:  Blood       Date:  2003-07-24       Impact factor: 22.113

6.  Bethesda proposals for classification of lymphoid neoplasms in mice.

Authors:  Herbert C Morse; Miriam R Anver; Torgny N Fredrickson; Diana C Haines; Alan W Harris; Nancy L Harris; Elaine S Jaffe; Scott C Kogan; Ian C M MacLennan; Paul K Pattengale; Jerrold M Ward
Journal:  Blood       Date:  2002-07-01       Impact factor: 22.113

Review 7.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

8.  Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions.

Authors:  W F Davidson; T Giese; T N Fredrickson
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

9.  Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression.

Authors:  Erika L Spaeth; Jennifer L Dembinski; A Kate Sasser; Keri Watson; Ann Klopp; Brett Hall; Michael Andreeff; Frank Marini
Journal:  PLoS One       Date:  2009-04-07       Impact factor: 3.240

10.  Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor.

Authors:  T Kurihara; G Warr; J Loy; R Bravo
Journal:  J Exp Med       Date:  1997-11-17       Impact factor: 14.307

View more
  126 in total

1.  Fbxw7 suppresses cancer metastasis by inhibiting niche formation.

Authors:  Kanae Yumimoto; Keiichi I Nakayama
Journal:  Oncoimmunology       Date:  2015-06-03       Impact factor: 8.110

2.  Mesenchymal stromal cells inhibit murine syngeneic anti-tumor immune responses by attenuating inflammation and reorganizing the tumor microenvironment.

Authors:  Jaime F Modiano; Beth A Lindborg; Ron T McElmurry; Mitzi Lewellen; Colleen L Forster; Edward A Zamora; Jerome Schaack; Donald Bellgrau; Timothy D O'Brien; Jakub Tolar
Journal:  Cancer Immunol Immunother       Date:  2015-08-07       Impact factor: 6.968

3.  Photopolymerizable Hydrogel-Encapsulated Fibromodulin-Reprogrammed Cells for Muscle Regeneration.

Authors:  Pu Yang; Chenshuang Li; Min Lee; Anna Marzvanyan; Zhihe Zhao; Kang Ting; Chia Soo; Zhong Zheng
Journal:  Tissue Eng Part A       Date:  2020-06-02       Impact factor: 3.845

4.  Histidine decarboxylase (HDC)-expressing granulocytic myeloid cells induce and recruit Foxp3+ regulatory T cells in murine colon cancer.

Authors:  Xiaowei Chen; Yoshihiro Takemoto; Huan Deng; Moritz Middelhoff; Richard A Friedman; Timothy H Chu; Michael J Churchill; Yan Ma; Karan K Nagar; Yagnesh H Tailor; Siddhartha Mukherjee; Timothy C Wang
Journal:  Oncoimmunology       Date:  2017-02-10       Impact factor: 8.110

5.  Emergence of spatial structure in the tumor microenvironment due to the Warburg effect.

Authors:  Carlos Carmona-Fontaine; Vanni Bucci; Leila Akkari; Maxime Deforet; Johanna A Joyce; Joao B Xavier
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

6.  Primary non-Hodgkin lymphoma of the right femur and subsequent metastasis to the left femur: A case report and literature review.

Authors:  Jing-Yu Hu; Dan Yu; Yao-Hui Wu
Journal:  Oncol Lett       Date:  2018-01-29       Impact factor: 2.967

7.  Tumor-infiltrating mesenchymal stem cells: Drivers of the immunosuppressive tumor microenvironment in prostate cancer?

Authors:  Timothy E Krueger; Daniel L J Thorek; Alan K Meeker; John T Isaacs; W Nathaniel Brennen
Journal:  Prostate       Date:  2018-11-28       Impact factor: 4.104

8.  The Glasgow Prognostic Score (GPS) is a novel prognostic indicator in advanced epithelial ovarian cancer: a multicenter retrospective study.

Authors:  Jiayu Zhu; Hua Wang; Cheng-Cheng Liu; Yue Lu; Hailin Tang
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-26       Impact factor: 4.553

9.  p38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion.

Authors:  Bangxing Hong; Haiyan Li; Mingjun Zhang; Jingda Xu; Yong Lu; Yuhuan Zheng; Jianfei Qian; Jeffrey T Chang; Jing Yang; Qing Yi
Journal:  Int J Cancer       Date:  2014-05-16       Impact factor: 7.396

10.  MFG-E8 Drives Melanoma Growth by Stimulating Mesenchymal Stromal Cell-Induced Angiogenesis and M2 Polarization of Tumor-Associated Macrophages.

Authors:  Kazuya Yamada; Akihiko Uchiyama; Akihito Uehara; Buddhini Perera; Sachiko Ogino; Yoko Yokoyama; Yuko Takeuchi; Mark C Udey; Osamu Ishikawa; Sei-Ichiro Motegi
Journal:  Cancer Res       Date:  2016-05-17       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.